Current HIV/AIDS Reports

, 8:288

HIV-Related Research in Correctional Populations: Now is the Time

  • Josiah D. Rich
  • David A. Wohl
  • Curt G. Beckwith
  • Anne C. Spaulding
  • Nathaniel E. Lepp
  • Jacques Baillargeon
  • Adrian Gardner
  • Ann Avery
  • Frederick L. Altice
  • Sandra Springer
  • On behalf of the Centers for AIDS Research—Collaboration on HIV in Corrections (CFAR-CHIC) Working Group
Behavioral Aspects of HIV Management (Ralph J. DiClemente and Jennifer Brown, Section Editors)

Abstract

The incarcerated population has increased to unprecedented levels following the 1970 US declaration of war on illicit drug use. A substantial proportion of people with or at risk for HIV infection, including those with substance use and mental health disorders, have become incarcerated. The overlapping epidemics of incarceration and HIV present a need for academic medical centers to collaborate with the criminal justice system to improve the health of incarcerated populations. With coordinated collaboration and new programmatic initiatives it is possible to reduce HIV-associated risk behaviors and the likelihood of acquisition and transmission of HIV. Centers for AIDS Research (CFAR), funded by the National Institutes of Health, have proactively responded to this need through Collaboration on HIV in Corrections (CHIC) to improve the diagnosis, treatment, linkage to care, and prevention of HIV. This collaboration serves as a model for aligning academic expertise with criminal justice to confront this challenge to individual and public health. This is especially relevant given recent evidence of the effectiveness of antiretroviral therapy in reducing HIV transmission (Cohen et al. N Engl J Med 365(6):493–505, 2011).

Keywords

HIV/AIDS Corrections Prison Jail Collaboration Academic 

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.Google Scholar
  2. 2.
    Pew Center on the States, One in 31: The Long Reach of American Corrections 2009: Washington, DC.Google Scholar
  3. 3.
    Maruschak LM et al. Pandemic influenza and jail facilities and populations. Am J Public Health. 2009;99 Suppl 2:S339–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Spaulding AC et al. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558.PubMedCrossRefGoogle Scholar
  5. 5.
    El-Sadr WM, Mayer KH, Hodder SL. AIDS in America–forgotten but not gone. N Engl J Med. 2010;362(11):967–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Springer SA, Azar MM, Altice FL. HIV, alcohol dependence, and the criminal justice system: a review and callfor evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse. 2011;37(1):12–21.Google Scholar
  7. 7.
    Springer SA et al. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Stephenson BL et al. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84–8.PubMedGoogle Scholar
  9. 9.
    Stephenson BL et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS. 2006;17(2):103–8.PubMedCrossRefGoogle Scholar
  10. 10.
    •• Rich JD, Wakeman SE, Dickman SL. Medicine and the epidemic of incarceration in the United States. N Engl J Med. 2011;364(22):2081-3. A disproportionate amount of incarceration in the US has been caused by the failed war on drugs and a failure to provide treatment to those with mental illnesses and addictions. While the medical and public health communities should capitalize on the opportunity to provide treatment to the largely uninsured, low-income, and minority population cycling through the criminal justice system, they also have the responsibility of advocating for alternatives to incarceration that address the health needs of underserved communities. PubMedCrossRefGoogle Scholar
  11. 11.
    Raimer BG, Stobo JD. Health care delivery in the Texas prison system: the role of academic medicine. JAMA. 2004;292(4):485–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Beckwith CG et al. Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS. 2007;21(1):41–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Kavasery R et al. A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One. 2009;4(11):e8056.PubMedCrossRefGoogle Scholar
  14. 14.
    Springer SA et al. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials. 2007;8(4):205–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Springer SA, Chen S, Altice FL. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.PubMedCrossRefGoogle Scholar
  16. 16.
    Lazzarini Z, Altice FL. A review of the legal and ethical issues for the conduct of HIV-related research in prisons. AIDS Public Policy J. 2000;15(3–4):105–35.PubMedGoogle Scholar
  17. 17.
    Sabol WJ, Minton TD, Harrison PM. Prison and jail inmates at midyear, 2006. U.S. Department of Justice, 2007. Document NCJ 217675.Google Scholar
  18. 18.
    ••Altice FL, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010;376(9738):367-87. This study provides an overview of comorbidities among HIV-positive people who use drugs and reviews treatment complications for those multiple conditions, particularly pharmacokinetic drug interactions and adherence problems.PubMedCrossRefGoogle Scholar
  19. 19.
    Lobato MN, Leary LS, Simone PM. Treatment for latent TB in correctional facilities: a challenge for TB elimination. Am J Prev Med. 2003;24(3):249–53.PubMedCrossRefGoogle Scholar
  20. 20.
    Mumola CJ, Karberg JC. Drug use and dependence, state and federal prisons, 2004. U.S. Department of Justice, 2006. Document NCJ 213530.Google Scholar
  21. 21.
    Mattick RP, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008(2):CD002207.Google Scholar
  22. 22.
    Binswanger IA et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65.PubMedCrossRefGoogle Scholar
  23. 23.
    Palepu A et al. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99(3):361–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Kinlock TW et al. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37(3):277–85.PubMedCrossRefGoogle Scholar
  25. 25.
    Karberg J, James D. Substance dependence, abuse, and treatment of jail inmates, 2002. 2005: Washington, D.C.Google Scholar
  26. 26.
    Mumola C. Substance abuse and treatment, state and federal prisoners, 1997. Justice UDo, 1999:1-16.Google Scholar
  27. 27.
    Hendershot CS et al. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.PubMedCrossRefGoogle Scholar
  28. 28.
    Palepu A et al. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health. 2003;80(4):667–75.PubMedCrossRefGoogle Scholar
  29. 29.
    James DJ, Glaze LE. Mental health problems of prison and jail inmates. 2006. Bureau of Justice Statistics.Google Scholar
  30. 30.
    Cook JA et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94(7):1133–40.PubMedCrossRefGoogle Scholar
  31. 31.
    Rivas-Vazquez RA et al. A relationship-based care model for jail diversion. Psychiatr Serv. 2009;60(6):766–71.PubMedCrossRefGoogle Scholar
  32. 32.
    Blankenship KM, Koester S. Criminal law, policing policy, and HIV risk in female street sex workers and injection drug users. J Law Med Ethics. 2002;30(4):548–59.PubMedCrossRefGoogle Scholar
  33. 33.
    Petitt W, Western B. Mass imprisonment and the life course: race and class inequality in U.S. incarceration. Am Soc Rev. 2004;69:151–69.CrossRefGoogle Scholar
  34. 34.
    Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–94.PubMedCrossRefGoogle Scholar
  35. 35.
    Jurgens R et al. Panel: rights of people in prison to HIV prevention, treatment and care. HIV AIDS Policy Law Rev. 2009;14(2):84–92.PubMedGoogle Scholar
  36. 36.
    Jafa K et al. HIV transmission in a state prison system, 1988-2005. PLoS One. 2009;4(5):e5416.PubMedCrossRefGoogle Scholar
  37. 37.
    Dolan K, Larney S. A review of HIV in prisons in Nepal. Kathmandu Univ Med J (KUMJ). 2009;7(28):351–4.Google Scholar
  38. 38.
    Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Marks G et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRefGoogle Scholar
  40. 40.
    Small W et al. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.PubMedCrossRefGoogle Scholar
  41. 41.
    Kinlock TW et al. A study of methadone maintenance for male prisoners: 3 month post-release outcomes. Crim Justice Behav. 2008;35(1):34–47.PubMedCrossRefGoogle Scholar
  42. 42.
    ••Baillargeon J, et al. Accessing antiretroviral therapy followiong release from prison. JAMA 2009;301(8):848-57. This study of 2115 HIV-positive inmates in Texas found significant interruptions in ART following release from prison, with only 5% of subjects filling a subsidized prescription within 10 days of release and 30% filling it within 60 days of release. This interruption in treatment creates heightened risks for adverse clinical outcomes, reservoirs of drug-resistant HIV, and greater infectiousness. PubMedCrossRefGoogle Scholar
  43. 43.
    Maru DS, Basu S, Altice FL. HIV control efforts should directly address incarceration. Lancet Infect Dis. 2007;7(9):568–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Khan MR, et al. Dissolution of primary intimate relationships during incarceration and associations with post-release STI/HIV risk behavior in a Southeastern City. Sex Transm Dis, 2010.Google Scholar
  45. 45.
    Maruschak L. HIV in prisons, 2006, B.o.J.S. US Department of Justice, Editor. 2007.Google Scholar
  46. 46.
    Dixon PS et al. Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med. 1993;95(6):629–35.PubMedCrossRefGoogle Scholar
  47. 47.
    Baillargeon J et al. Psychiatric disorders and suicide in the nation's largest state prison system. J Am Acad Psychiatry Law. 2009;37(2):188–93.PubMedGoogle Scholar
  48. 48.
    Wakeman SE, McKinney ME, Rich JD. Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med. 2009;24(7):860–2.PubMedCrossRefGoogle Scholar
  49. 49.
    Zahari MM et al. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse. 2010;36(1):31–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Stuckler D et al. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A. 2008;105(36):13280–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Podlekareva DN et al. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS. 2009;23(18):2485–95.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Josiah D. Rich
    • 1
    • 2
    • 3
  • David A. Wohl
    • 4
  • Curt G. Beckwith
    • 1
    • 2
    • 3
  • Anne C. Spaulding
    • 5
  • Nathaniel E. Lepp
    • 10
  • Jacques Baillargeon
    • 6
  • Adrian Gardner
    • 2
  • Ann Avery
    • 7
    • 8
  • Frederick L. Altice
    • 9
  • Sandra Springer
    • 9
  • On behalf of the Centers for AIDS Research—Collaboration on HIV in Corrections (CFAR-CHIC) Working Group
  1. 1.Brown University Medical SchoolProvidenceUSA
  2. 2.The Miriam HospitalProvidenceUSA
  3. 3.The Center for Prisoner Health and Human RightsProvidenceUSA
  4. 4.University of North CarolinaChapel HillUSA
  5. 5.Rollins School of Public HealthEmory UniversityAtlantaUSA
  6. 6.University of Texas Medical BranchGalvestonUSA
  7. 7.Case Western Reserve UniversityClevelandUSA
  8. 8.MetroHealth Medical CenterClevelandUSA
  9. 9.Yale University School of MedicineNew HavenUSA
  10. 10.New York Medical CollegeValhallaUSA

Personalised recommendations